Based on the analysis described above, a Kaplan-Maier survival curve analysis was constructed for the INCAN cohort, and better overall survival (statistically significant at p≤0.005) was observed for all lung carcinoma patients with lower MEOX2 and GLI-1 protein co-expression levels (statistically significant at p=0.009 and p=0.002, respectively) (Figure 9A). The gene discussed is MEOX2; the disease is lung carcinoma.